目的 探讨细辛脑注射剂不良反应(adverse reactions,ADR)发生的规律及特点,为临床合理用药提供参考。方法 通过检索国内有关数据库,对细辛脑注射剂ADR病例报告进行文献汇总,统计患者的基本信息、用药情况、ADR等信息,并将危及生命的严重ADR归为本次研究的重点。结果 纳入研究的85例中,重型ADR 41例,构成比48.23%;年龄小于6岁的患者54例(63.41%),发生重型ADR 28例,构成比68.29%; 90.58%ADR出现在用药10 min内,80.48%的重型ADR发生时间小于5 min;ADR累及循环系统156例次,占34.51%;呼吸系统116例次,占25.66%。有2例经治疗无效死亡,1例经治疗13 d后失视,其余82例均经治疗后症状好转。结论 细辛脑注射剂引起的ADR以过敏反应为主,其发生与多种因素有关,发生重型ADR如不及时救治可导致死亡,建议临床要做好ADR的监测与防范。
Abstract
Objective To study the patterns and characteristics of adverse reactions induced by asarone injection and to provide reference for rational use of drug by clinician.Methods By retrieving data from domestic databases, we collected literature about cases of ADRs and information about the patients and medication. Life-threatening cases of ADRs were chosen as the severe ADR in this study.Results Among the eighty-five cases of adverse reactions in this study, there were forty-one cases of severe ADRs, accounting for 48.23%. Fifty-four of the patients were under six years old (63.41%), twenty-eight of whom were severe cases of ADRs, making up 68.29%. 90.58% of the adverse reactions occurred within 10 minutes of administration and 80.48% of the cases of severe ADRs took place in less than 5 minutes. The circulation system was damaged by adverse reactions 156 times, accounting for 34.51%, while the respiratory system was impaired 116 times, accounting for 25.66%. Two patients died from futile treatment, one patient lost eyesight after 13 days of treatment, and the remaining eighty-two patients improved after treatment.Conclusions Adverse reactions caused by asarone injection are mainly allergic reactions and related to multiple factors. Severe ADRs can lead to death unless dealt with without delay. Hence, it is recommended that clinicians should monitor and prevent adverse reactions induced by asarone injection.
关键词
细辛脑注射剂 /
不良反应 /
过敏性休克 /
分析 /
防治
Key words
asarone injection /
adverse reactions /
anaphylactic shock /
analysis /
countermeasures
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 国家药监局药品评价中心,关于警惕细辛脑注射液的严重过敏反应的通报[Z].2011-06-10.
[2] 黄 亮,陈 力,韩 璐,等.细辛脑注射液118例不良反应文献分析[J].中南药学,2011,9(2):157-160.
[3] 李晓辉,陈兰兰,薛金莲.细辛脑注射液46例不良反应临床分析[J].陕西药学杂志,2014,43(16):1965-1966.
[4] 李文平.细辛脑注射液致过敏反应5例的临床观察[J].中国医药指南,2011,9(7):139.
[5] 李 蓓. 细辛脑注射剂致不良反应50例分析[J].中国医药导刊,2013,15(6):1059-1060.
[6] 夏旭东,龚立雄,夏 明,等.412例细辛脑注射液ADR/ADE报告分析[J].中国药物警戒,2012,9(1):47-51.
[7] 吕娟丽,王凤林,刘 华,等.注射用12种复合维生素致过敏性休克1例[J].武警医学,2016,27(4):401-403.
[8] 王慧玲.注射用细辛脑引起过敏性休克1例[J].中国实用医药,2014,9(24):187-189.
[9] 张玉霞.药物引发的双硫仑样反应20例[J].临床合理用药杂志,2014,7(4):10.
[10] 郭海莉. 注射用头孢哌酮钠舒巴坦钠联合细辛脑注射液致双硫仑样反应1例[J].中国药物警戒,2014,11(3):185-186.
[11] 杨吉庆,李彦明,王 刚.细辛脑注射剂致过敏性休克死亡1例[A].中国法医学会·全国第十七届法医临床学学术研讨会论文集 ,哈尔滨:2014:644-645.
[12] 李家卓,刘 冀,刘家明,等.细辛脑注射液致过敏性休克死亡[J]. 药物不良反应杂志,2010,12(2):141-142.
[13] 杨爱民,程 毅.静脉滴注细辛脑注射液致过敏反应 3 例[J].中国医学创新,2010,7(32):192.
[14] 张亚浩. 注射用细辛脑致变态反应10例临床分析[J].西北药学杂志,2014,29(3):276,
[15] 李振虎,王化龙,刘艳庭,等.聚山梨酯80 诱发类过敏反应机制研究[J].中国新药杂志,2016,25(23):2664-2669.